Ganciclovir and Acyclovir Reduce the Risk of Post‐Transplant Lymphoproliferative Disorder in Renal Transplant Recipients
Top Cited Papers
Open Access
- 1 December 2005
- journal article
- clinical trial
- Published by Elsevier in American Journal of Transplantation
- Vol. 5 (12) , 2894-2900
- https://doi.org/10.1111/j.1600-6143.2005.01115.x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Post-Transplant Lymphoproliferative DisordersAnnual Review of Medicine, 2005
- Randomized controlled trial of sequential intravenous and oral ganciclovir versus prolonged intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in high-risk cytomegalovirus-seronegative liver transplant recipients with cytomegalovirus-seropositive donorsTransplantation, 2004
- Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation1Transplantation, 2003
- Persistent epstein-barr virus infection: unrestricted latent and lytic viral gene expression in healthy immunosuppressed transplant recipients1Transplantation, 2002
- Anti-viral prophylaxis reduces the incidence of lymphoproliferative disease in lung transplant recipientsThe Journal of Heart and Lung Transplantation, 2002
- Epstein‐Barr Virus Gene Expression in the Peripheral Blood of Transplant Recipients with Persistent Circulating Virus LoadsThe Journal of Infectious Diseases, 2000
- Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal TransplantationNew England Journal of Medicine, 1999
- PREVENTION AND PREEMPTIVE THERAPY OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN PEDIATRIC LIVER RECIPIENTS1Transplantation, 1998
- POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER IN RENAL ALLOGRAFT RECIPIENTSTransplantation, 1993
- EPSTEIN-BARR VIRUS, IMMUNODEFICIENCY, AND B CELL LYMPHOPROLIFERATIONTransplantation, 1985